Bentham Science Logo

Current Signal Transduction Therapy

Volume 14, 2 Issues, 2019
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Open Access Articles










In vivo Radiosensitization of Human Glioma U87 Cells Induced by Upregulated Expression of DUSP-2 after Treatment with Curcumin

, 2015; 10(2): 119 - 125

Lei Zhang, Xiaopeng Ding, Jin Huang, Chen Jiang, Boqiang Cao, Yu Qian, Chao Cheng, Minchao Dai, Xiaoyi Guo and Junfei Shao




The Role of Diabetes in Molecular Pathogenesis of Cancer

, 2015; 10(1): 10 - 16

Arthur Matyszewski, Anna M. Czarnecka, Piotr Korzen, Ilan J. Safir, Wojciech Kukwa and Cezary Szczylik




Strategies of Functional Foods Promote Sleep in Human Being

, 2014; 9(3): 148 - 155

Yawen Zeng, Jiazhen Yang, Juan Du, Xiaoying Pu, Xiaomen Yang, Shuming Yang and Tao Yang




Metastasis-Initiating Cells in Renal Cancer

, 2013; 8(3): 240 - 246

Mohammed I. Khan, Anna M. Czarnecka, Renata Duchnowska, Wojciech Kukwa and Cezary Szczylik





Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma

, 2013; 8(3): 210 - 218

Anna Kornakiewicz, Wojciech Solarek, Zofia F. Bielecka, Fei Lian, Cezary Szczylik and Anna M. Czarnecka




Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops

, 2013; 8(3): 193 - 202

Viktoria von Manstein, Chul Min Yang, Diane Richter, Natalia Delis, Vida Vafaizadeh and Bernd Groner






Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
USA

Biography View Full Editorial Board

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog